In light of COVID-19, here’s what multinational businesses should take into account with regard to intangible asset valuation and intercompany transference.
Your existing (or pending) advance transfer pricing agreement with tax authorities could be affected by the COVID-19 crisis; here are the issues you should be aware of in the months ahead.
Is there a difference in fair value vs. market value? When it comes to valuations, yes, there is. This post breaks it down.
When it comes to intercompany transactions, accounting for COVID-19 could potentially impact your transfer pricing risk. Here’s what to think about before making changes to intercompany service charges.
Business is not “as usual” in the time of COVID-19; here’s why you should review your intercompany agreements now in light of the new reality, and questions to consider when amending.
The present value of terminal value is critical in using the income approach for valuation. Here are the methods to use—and the limitations of each.